Most strikingly, multiple trials have now shown that GLP-1 agonists can lead to the resolution of MASH, a severe form of fatty liver disease, without worsening of liver fibrosis, which is a common adverse outcome seen with some current medications
Certainly, maintaining these healthy habits becomes even more crucial after discontinuing GLP-1 treatment, as research shows most patients regain significant weight without proper planning
Other trials investigate how retatrutide compares to drugs such as tirzepatide, which is already showing promise when paired with menopausal hormone therapy to achieve increased weight loss
Stress Management Adaptogenic herbs (ashwagandha, rhodiola), meditation, yoga, and breathwork to lower cortisol levels that promote weight gain and insulin resistance
Hepatitis A Vaccine Inactivated